Golden Recursion Inc. logoGolden Recursion Inc. logo
Advanced Search
Reverie Labs

Reverie Labs

Reverie Labs is a drug dicovery company that uses machine learning founded by Jonah Kallenbach.

Reverie Labs is a company developing machine learning drug discovery platform for cancer therapeutics. It was established in 2017 by Jonah Kallenbach, Ankit Gupta, and Connor Duffy. Reverie Labs has received funding investors such as Soma Capital, Wei Guo, and Uncommon Denominator. The company is headquartered in Boston, Massachusetts, United States.

Product and service

Reverie Labs' technology is designed to be used in developing new therapeutics compound. It specifically aims to incorporate machine learning techniques to decrease the amount of time needed during the lead development phase. Some of the methodologies used include active learning to build client-specific databases and in silico testing on newly discovered molecules. Reverie Labs is focusing on discovering and developing their own cancer therapeutics, although it also offers its lead development technology for pharmaceutical companies' use.

Timeline

February 2021
Reverie Labs raises a $25,000,000 series A round from Ridgeback Capital.

Funding Rounds

Patents

Further Resources

Title
Author
Link
Type
Date

Reverie Labs

Web

Reverie Labs uses new machine learning algorithms to fix drug development bottlenecks

Catherine Shu

Web

March 16, 2018

Scaling Drug Development with Containerized Machine Learning

Ankit Gupta

Web

March 7, 2020

Training Transformers for Practical Drug Discovery with Tensor2Tensor

Gabe Grand

Web

April 20, 2020

News

Search on Google
Search on Bing

References

Golden logo
By using this site, you agree to our Terms & Conditions.